$ATNM great opportunity to add on dips  before the announcement hoc interim analysis for Phase 3 trial to be exercised in June. $jnj $mrk $pfe $abbv $bmy $biib $vrtx $sgen $bmrn $tril $tgtx $cldx $aveo $pgen $gild $rhhby $clsn $sls $cala $clsn $sgmo $adap $nvax $arna $mreo $mrna https://t.co/ScLkys31b5